Report Highlights
The global market for fetal monitoring, diagnostics and predictive tests is estimated to increase from $10.4 billion in 2022 to reach $13.6 billion by 2027, at a compound annual growth rate (CAGR) of 5.6% from 2022 through 2027.
Report Includes
- 17 data tables and 54 additional tables
- Detailed overview and an up-to-date analysis of the global market for fetal monitoring, prenatal diagnostics, and predictive tests
- Analyses of the global market trends, with historic market revenue for 2019-2021, 2022, and projections of compound annual growth rates (CAGRs) through 2027
- Highlights of the current and future market potential for fetal monitoring products, diagnostic and predictive tests, along with a detailed analysis of the competitive environment, industry trends, opportunities and penetration of emerging technologies within the industry
- Estimation of the actual market size and revenue forecast for fetal monitoring and related markets in USD million values, and its corresponding market share analysis based on the product type, sample type, test type, end user, and region
- A comparative study of each category of fetal monitoring and diagnosis in addition to new technologies and developments, manufacturer and supplier competition, and the changing environment of the market due to the increasing awareness of expectant mothers
- Updated information on the key mergers and acquisition deals, agreements, collaborations and other impactful strategies adopted by key players in the global market for fetal monitoring products, diagnostic and predictive tests
- Identification of the major stakeholders and analysis of the company competitive landscape based on their recent market developments, financial performance, and segmental revenues
- Descriptive company profiles of the leading global players, including Abbott Laboratories, Abcam plc, Ansh Labs LLC, Beckman Coulter Inc., Contect Medical Systems Co. Ltd., and Dragerwerk AG & Co. KGaA
Report Scope
This report aims to provide a comprehensive study of the global market for fetal monitoring, diagnostics, and predictive tests, both in terms of quantitative and qualitative data, to help businesses develop growth strategies, assess the market landscape, analyze their positions in the current marketplace, and make informed business decisions regarding fetal monitoring, diagnostics, and predictive tests.
An in-depth analysis of the global fetal monitoring, diagnostics and predictive tests market includes historical data and market projections on sales by application, product type, and end user. It describes the different types of fetal monitoring, diagnostics and predictive tests and their current and historical market revenues. This report also categorizes the global fetal monitoring, diagnostics and predictive tests market based on the region (North America, Europe, and Rest of the World).
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market shares.
Report Synopsis
| Report Metrics | Details | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Base year considered | 2021 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Forecast period considered | 2022-2027 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Base year market size | $10.1 billion | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market size forecast | $13.6 billion | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Growth rate | CAGR of 5.6% for the forecast period of 2022-2027 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Units considered | $ Millions | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Segments covered | type and region | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Regions covered | North America, Europe, Asia-Pacific, and Rest of the World | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Countries covered | United States, Canada, France, Germany, Italy, United Kingdom, Spain, Russia, China, Japan, India, South Korea, Australia, Singapore, Latin America, Middle East and Africa | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Companies studied |
|
Frequently Asked Questions (FAQs)
- GE Healthcare
- Siemens Healthineers AG
- Koninklijke Philips N.V.
- Beckman Coulter Inc.
- Esaote SpA
Analyst Credentials
BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.
Report Highlights
The global market for fetal monitoring, prenatal diagnostics, predictive tests and neonatal monitoring was valued at roughly $8.6 billion in 2013 and about $9.0 billion in 2014. This market is expected to reach about $10.9 billion by 2019, with a compound annual growth rate (CAGR) of 4.0% from 2014 to 2019.
Report Includes
- An overview of the global markets for fetal monitoring, diagnostics, and predictive tests.
- Analyses of global market trends, with data from 2013 and 2014, and projections of compound annual growth rates (CAGRs) through 2019.
- Information on the strengths and weaknesses of each category of fetal monitoring and diagnosis in addition to new technologies and developments, manufacturer and supplier competition, and the changing environment of the market due to the increasing awareness of expectant mothers.
- Discussion covering acquisitions, mergers, and alliances by companies and global organizations.
- Comprehensive company profiles of major players in the industry.
Report Highlights
The global market for fetal monitoring, diagnostics, and predictive tests reached approximately $6.2 billion in 2010. The market is expected to rise at a compound annual growth rate (CAGR) of 4.4% and reach approximately $8 billion by 2016.
Related Reports
Routine Health Screening Market
The global market for routine health screening is expected to grow from $59.7 billion in 2024 and is projected to reach $82.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 6.8% during the forecast period of 2024 to 2029.
Global Prenatal Testing Market
The global market for prenatal testing is expected to grow from $10.9 billion in 2023 and projected to reach $19.8 billion by the end of 2028, at a compound annual growth rate (CAGR) of 12.6% during the forecast period of 2023 to 2028.
Patient Monitoring Devices: Global Markets
The global patient monitoring devices market should reach $42.7 billion by 2022 and more than $65.4 billion by 2027, with a compound annual growth rate (CAGR) of 8.9% during the forecast period of 2022-2027.
Global Fetal and Neonatal Monitoring Devices Market
The global market for fetal and neonatal monitors should grow from $4.8 billion in 2020 to $6.4 billion by 2025, at a compound annual growth rate (CAGR) of 6.1% for the period of 2020-2025.
Recent Reports
Surgical Equipment: Technologies and Global Markets
The global market for surgical equipment and technologies was valued at $37.6 billion in 2023. This market is expected to grow from $40.0 billion in 2024 to $56.6 billion by 2029, at a compound annual growth rate (CAGR) of 7.2% from 2024 to 2029.
Conventional and Alternative Pain Treatment Markets
The global market for conventional and alternative pain treatment is expected to grow from $96.2 billion in 2024 and is projected to reach $144.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.4% during the forecast period of 2024 to 2029.
CRISPR Technology: Global Markets
The global market for CRISPR technology was valued at $3.4 billion in 2023. This market is expected to grow from $3.8 billion in 2024 to $7.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 14.4% from 2024 to 2029.
Chronic Disease Management: Therapeutics, Device Technologies and Global Markets
The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.
Medical Devices: Technologies and Global Markets
The global market for medical devices reached $739.6 billion in 2023. It is expected to grow from $810.4 billion in 2024 to $1.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Top Trending Reports
Single-use Technologies for Biopharmaceuticals: Global Markets
The global market for single-use technologies for biopharmaceuticals is expected to grow from $6.5 billion in 2024 and is projected to reach $11.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.6% during the forecast period of 2024 to 2029.
Cell and Gene Therapy Tools, and Reagents: Global Markets
The global market for Cell and Gene Therapy (CGT) Tools and Reagents is estimated to increase from $10.0 billion in 2024 to reach $16.7 billion by 2029, at a compound annual growth rate (CAGR) of 10.8% from 2024 through 2029.
Medical Devices Industry: Competitive Landscape
The global market for medical devices is estimated to increase from 810.4 billion in 2024 to reach $1.3 trillion by 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Global Market Opportunities and Competitive Landscape for CDMO
The global CDMO market was valued at $128.0 billion in 2023. This market is expected to grow from $136.6 billion in 2024 to $191.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.0% from 2024 to 2029.
Chronic Disease Management: Therapeutics, Device Technologies and Global Markets
The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More